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calculated 191.7cGy. The error in film measurement increases from 
1.4cGy to 2.2cGy if a single film is used instead of a 5-film sample. 
Conclusions: Submillimeter point dose measurement with EBT2 film is 
shown to be very accurate. Signal extraction from such a small spatial 
area allows for accurate measurement in small-fields, steep dose 
gradients, and non-flattened beams.  
References: 
1. Gafchromic EBT2 Self-Developing Film for Radiotherapy Dosimetry, 
ISP White Paper, Revision 1, February, 2009. 
   
PO-0763   
Optical fibre radiation detector for radiotherapy dosimetry 
P. Woulfe1, D. McCarthy2, S. O'Keefe2, E. Lewis2, J. Cronin1 
1Galway Clinic, Department of Medical Physics, Galway, Ireland 
Republic of  
2University of Limerick, Optical Fibre Sensor Research Centre, 
Limerick, Ireland Republic of  
 
Purpose/Objective: An optical fibre sensor for use in radiotherapy 
dosimetry is presented. The sensor is based on a scintillating material 
coated plastic optical fibre (POF), which emits visible light when 
exposed to low level ionising radiation. The incident level of ionising 
radiation can be determined by analysing the observed emission 
spectra. The work presented reports on the design of the sensor and 
the stability of the sensor during measurement of incident x-ray 
energy. Initial testing of the sensor on a Linac is presented, 
demonstrating the suitability of such a sensor for a range of 
radiotherapy dosimetry applications, including the area of small field 
dosimetry. 
Materials and Methods: A 1 metre PMMA (Polymethyl Methacrylate) 
plastic optical fibre of 1mm diameter is prepared.The optical fibre 
cable end was polished, an epoxy resin and hardener mix,containing 
the scintillation material, was then encapsulated around the fibre 
cable end using an injection method and allowed to set. The radiation 
source used was a Siemens Artiste, with a water equivalent phantom 
of varying depths. The sensor was connected to a fluorescent 
spectrometer using a 19 meter long POF cable. The spectrometer and 
a computer for analysing the resultant optical signal were located at 
the control console. The optical fibre coated with a scintillation 
material fluoresces when subjected to ionising radiation. Upon 
scintillation, the low level light permeates the fibre optic cable end 
and the spectrometer placed at the distal end of the POF cable 
measures the received optical signal. The amount of radiation 
incident on the sensor is directly related to the measured intensity of 
the received spectrum at the preselected wavelengths. The 
spectrometer detects and records low level light from the sensor and 
detects any changes in optical intensity levels that are recorded via 
LabVIEW software. 
 
 Results: The optical fibre sensor was initially tested for its response 
to 100MU (Monitor Units,where 1MU = 1cGy when SSD (surface to 
source distance) is 100cm at a depth of Dmax.) at 6MV photon energy 
using a 1.5cm build-up. The peak intensity of the received fluorescent 
signal, at 544nm, was monitored. During irradiation the sensor 
demonstrates a stable response and then returns to its original off 
state when the radiation stops. The sensor was then tested at 
repeated radiation doses of 100MU at 15MV to test for the stability of 
the optical fibre sensor at repeated exposures. 
 
  
Conclusions: The optical fibre sensor was investigated for its response 
to known incident radiation exposure patterns, repeatability and 
stability of measurement. The sensor demonstrated excellent 
response to a wide range of exposure conditions including different 
levels of ionising energy, dose rates and exposure duration. The 
results show that the sensor is capable of realtime, accurate and 
repeatable radiation dose measurements with a maximum variance of 
± 2% from a Linac. 
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Purpose/Objective: Radiochromic films such as Gafchromic EBT or 
EBT2 offer an excellent spatial resolution which is beneficial for dose 
verification in highly conformal radiation therapy such as IMRT or 
proton therapy. Recently, a new generation of these films, EBT3, has 
become available. As composition and thickness of the sensitive layer 
are the same as for the previous EBT2 films, a similar dosimetric 
performance is expected, in particular with respect to the known 
energy dependence of the films. The side orientation dependence, 
which is reported for EBT2 films, has been eliminated in EBT3 films by 
a symmetric layer configuration.  
Materials and Methods: The general EBT3 film characteristics such as 
read-out orientation dependence and post-exposure darkening growth 
are evaluated and compared to EBT2 films. Film response has been 
investigated in clinical photon and proton beams. The energy 
dependence of both, EBT2 and EBT3 films, has been studied for low 
proton energies (<=20MeV) as predominating in the vicinity of the 
Bragg peak but also up to a maximum energy of 200 MeV. 
Results: In general, EBT3 show a comparable performance to EBT2 
films, moreover, orientation dependence with respect to film side is 
completely eliminated in EBT3 films. Response differences of EBT2and 
EBT3 films are of the same order of magnitude as batch-to-batch 
variations observed for EBT2 films. Photon and proton exposure show 
similar response for both generations of EBT films. Depth dose 
measurements show an under-estimation of dose by up to 20 % in the 
Bragg peak region for both types of film.  
Conclusions: EBT3 and its precursor EBT2 have similar dosimetric 
performance and can, thus, be applied to dose verification in IMRT in 
the same way. Dose under-response in the Bragg peak region has to be 
taken into account if films are to be applied for dose verification in 
proton therapy.  
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Purpose/Objective: In the radiotherapy Treatment Planning Systems 
(TPS) various calculation algorithms are used (Pencil Beam 
Convolution PBC, analytical anisotropic algorithm AAA, Monte-Carlo). 
The accuracy of dose calculations has to be verified. Numerous 
phantom types and detectors are proposed to verify the TPS 
calculations by dosimetric measurements. A heterogeneous cubic-
shape phantom has been designed for this purpose within a 
Coordinated Research Project of the IAEA. 
